InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Chang David D, Chairman & CEO. Director active across 2 companies, notably Allogene Therapeutics, Inc.. In total, 3 disclosures have been published. Total volume traded: €165k. The latest transaction was disclosed on 15 March 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€165,28923,648 shares@ €6.98960.024% mcap28.8% of flow
Common Stock
SEC:0001214659-22-004085:0·
€408,86227,410 shares@ €14.91650.13% mcap100.0% of flow
Common Stock
SEC:0001214659-21-005927·
€408,86227,410 shares@ €14.91650.059% mcap71.2% of flow
Common Stock
SEC:0001214659-21-005927:0·
3 of 3 declarations
About Chang David D
David D. Chang is the President and CEO of Allogene Therapeutics, Inc. He oversees the operations and strategy of the company, bringing his expertise to foster growth and innovation.
